Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lorena Rodriguez-Martinez"'
Autor:
Lorena Rodriguez-Martinez, Cristina García-Moreno, Eva Perez-Pampin, María J. Gómara, Juan C. Sarmiento-Monroy, Yolanda Lopez-Golán, José A. Gómez-Puerta, Antonio Mera-Varela, Carmen Conde, Raimon Sanmartí, Isabel Haro, Antonio González
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-14 (2023)
Abstract Background Autoantibodies are critical elements in RA pathogenesis and clinical assessment. The anti-malondialdehyde-acetaldehyde (anti-MAA) antibodies are potentially useful because of their claimed high sensitivity for all RA patients, inc
Externí odkaz:
https://doaj.org/article/fe7bfc8d419849f68d300c670efe5da0
Autor:
Virginia S. Muir, Cliff Rims, Christina Gerstner, Jane H. Buckner, Vivianne Malmström, Lorena Rodriguez Martinez, Jing Song, Eddie A. James, Anja Schwenzer, Alicia Wong, David Arribas-Layton, Sara Turcinov, Kim S. Midwood
Publikováno v:
JCI Insight, Vol 6, Iss 5 (2021)
JCI Insight
JCI Insight
Tenascin-C (TNC), an extracellular matrix protein that has proinflammatory properties, is a recently described antibody target in rheumatoid arthritis (RA). In this study, we utilized a systematic discovery process and identified 5 potentially novel
Autor:
Francisco José Toja-Camba, Laura García-Quintanilla, Lorena Rodríguez-Martinez, Julia Tomine, Francisco Cajade-Pascual, Carolina Feitosa, Irene Zarra-Ferro, Manuel Barreiro-De-Acosta, Jaime González-López, Cristina Mondelo-García, Anxo Fernández-Ferreiro
Publikováno v:
Pharmaceutics, Vol 15, Iss 11, p 2615 (2023)
The introduction of point-of-care (POC) assays into clinical practice in patients with inflammatory disease enables on-demand therapeutic decision making. The aim of this study was to compare the POC test Quantum blue (Bühlmann Laboratories) for inf
Externí odkaz:
https://doaj.org/article/9d517633eb60463787ce44eab7e8db40
Autor:
Lorena Rodríguez-Martínez, Ana Castro-Balado, Gonzalo Hermelo-Vidal, Enrique Bandín-Vilar, Iria Varela-Rey, Francisco José Toja-Camba, Teresa Rodríguez-Jato, Ignacio Novo-Veleiro, Pablo Manuel Varela-García, Irene Zarra-Ferro, Miguel González-Barcia, Cristina Mondelo-García, Jesús Mateos, Anxo Fernández-Ferreiro
Publikováno v:
Pharmaceutics, Vol 15, Iss 8, p 2099 (2023)
Outpatient parenteral antimicrobial therapy (OPAT) with continuous infusion pumps is postulated as a very promising solution to treat complicated infections, such as endocarditis or osteomyelitis, that require patients to stay in hospital during exte
Externí odkaz:
https://doaj.org/article/7b59e2a9259d47b79bd574d5c9dd39b7
Autor:
Manuel Busto-Iglesias, Lorena Rodríguez-Martínez, Carmen Antía Rodríguez-Fernández, Jaime González-López, Miguel González-Barcia, Begoña de Domingo, Luis Rodríguez-Rodríguez, Anxo Fernández-Ferreiro, Cristina Mondelo-García
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 766 (2023)
Biological drugs, especially those targeting anti-tumour necrosis factor α (TNFα) molecule, have revolutionized the treatment of patients with non-infectious uveitis (NIU), a sight-threatening condition characterized by ocular inflammation that can
Externí odkaz:
https://doaj.org/article/8c4d486997494c368dbb809f366f0433
Autor:
Ana Castro-Balado, Enrique Bandín-Vilar, Andrea Cuartero-Martínez, Laura García-Quintanilla, Gonzalo Hermelo-Vidal, Xurxo García-Otero, Lorena Rodríguez-Martínez, Jesús Mateos, Manuela Hernández-Blanco, Pablo Aguiar, Irene Zarra-Ferro, Miguel González-Barcia, Cristina Mondelo-García, Francisco J. Otero-Espinar, Anxo Fernández-Ferreiro
Publikováno v:
Pharmaceutics, Vol 14, Iss 10, p 2194 (2022)
Cystinosis is a rare genetic disorder characterized by the accumulation of cystine crystals in different tissues and organs causing, among other symptoms, severe ocular manifestations. Cysteamine eye drops are prepared in hospital pharmacy department
Externí odkaz:
https://doaj.org/article/e65cc2c55cec4ea3b08449da511c4d45
Autor:
Cristina Regueiro, Lorena Rodríguez-Martínez, Laura Nuño, Ana M. Ortiz, Alejandro Villalba, Dora Pascual-Salcedo, Ana Martínez-Feito, Isidoro González-Alvaro, Alejandro Balsa, Antonio Gonzalez
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-7 (2019)
Abstract Background The patients with RA benefit from early identification soon after the first clinical symptoms appear. The 2010 ACR/EULAR classification criteria were developed to fulfill this need and their application has been demonstrated to be
Externí odkaz:
https://doaj.org/article/318f3261d0e94e3fb9e23670b1740da1
Autor:
Lorena Rodríguez-Martínez, Cristina Regueiro, Sámer Amhaz-Escanlar, Carmen Pena, Paloma Herbello-Hermelo, Antonio Moreda-Piñeiro, Javier Rodriguez-Garcia, Antonio Mera-Varela, Eva Pérez-Pampín, Antonio González
Publikováno v:
Diagnostics, Vol 12, Iss 2, p 352 (2022)
Patients with rheumatoid arthritis (RA) show autoantibodies against post-translational protein modifications (PTMs), such as anti-citrullinated protein antibodies. However, the range of recognized PTMs is unknown. Here, we addressed four PTMs: chlori
Externí odkaz:
https://doaj.org/article/3f09cc9b925e4015b598fe39b05e5848
Autor:
Jing Song, Anja Schwenzer, Alicia Wong, Sara Turcinov, Cliff Rims, Lorena Rodriguez Martinez, David Arribas-Layton, Christina Gerstner, Virginia S. Muir, Kim S. Midwood, Vivianne Malmström, Eddie A. James, Jane H. Buckner
Publikováno v:
JCI Insight, Vol 6, Iss 5 (2021)
Tenascin-C (TNC), an extracellular matrix protein that has proinflammatory properties, is a recently described antibody target in rheumatoid arthritis (RA). In this study, we utilized a systematic discovery process and identified 5 potentially novel
Externí odkaz:
https://doaj.org/article/817bed96baa04ee0b9d77c2c5b9df132